KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Other Non-Current Liabilities: 2009-2024

Historic Other Non-Current Liabilities for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $713.0 million.

  • Bausch Health Companies' Other Non-Current Liabilities rose 4.72% to $843.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $843.0 million, marking a year-over-year increase of 4.72%. This contributed to the annual value of $713.0 million for FY2024, which is 8.12% down from last year.
  • Latest data reveals that Bausch Health Companies reported Other Non-Current Liabilities of $713.0 million as of FY2024, which was down 8.12% from $776.0 million recorded in FY2023.
  • Bausch Health Companies' 5-year Other Non-Current Liabilities high stood at $1.0 billion for FY2020, and its period low was $653.0 million during FY2021.
  • Over the past 3 years, Bausch Health Companies' median Other Non-Current Liabilities value was $741.0 million (recorded in 2022), while the average stood at $743.3 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first increased by 18.92% in 2020, then slumped by 35.47% in 2021.
  • Over the past 5 years, Bausch Health Companies' Other Non-Current Liabilities (Yearly) stood at $1.0 billion in 2020, then slumped by 35.47% to $653.0 million in 2021, then climbed by 13.48% to $741.0 million in 2022, then climbed by 4.72% to $776.0 million in 2023, then decreased by 8.12% to $713.0 million in 2024.